Vaginal estrogen therapy in postmenopausal breast cancer patients treated with aromatase inhibitors

Moegele, M. and Buchholz, S. and Seitz, S. and Ortmann, Olaf (2012) Vaginal estrogen therapy in postmenopausal breast cancer patients treated with aromatase inhibitors. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 285 (5). pp. 1397-1402. ISSN 0932-0067,

Full text not available from this repository. (Request a copy)

Abstract

Breast cancer is the most frequent cancer among women with about 1.38 million new cases worldwide every year. Most of these patients are postmenopausal and suffer from hormone receptor positive breast tumors. About 50% of postmenopausal women between 50 and 60 years and 72% of women over 70 years suffer from vulvovaginal athrophy (VVA). Adjuvant treatment with aromatase inhibitors (AIs) improves outcomes in postmenopausal women with hormone receptor positive early stage breast cancer compared with tamoxifen. A frequent side effect of AI use is VVA with symptoms like vaginal dryness, vaginitis, pruritus, dyspareunia and cystitis. We searched major databases (i.e. pubmed) with the following selection criteria: breast cancer, hormone therapy, vaginal estrogen, aromatase inhibitor, vaginal atrophy, serum estrogen levels. Vaginal administration of estradiol is a well known and safe alternative to systemic estrogen therapy, but studies demonstrated significant increases in plasma concentrations of estradiol. Such observations have also been reported in postmenopausal breast cancer patients treated with AIs. Further studies are needed to explore risk of breast cancer recurrence after vaginal estrogen application for patients on adjuvant endocrine therapy with AIs.

Item Type: Article
Uncontrolled Keywords: HORMONE-REPLACEMENT THERAPY; QUALITY-OF-LIFE; WOMEN; ESTRIOL; ATROPHY; TRIAL; CREAM; RISK; METAANALYSIS; PROGESTIN; Breast cancer; Hormone therapy; Vaginal estrogen; Aromatase inhibitor
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Frauenheilkunde)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 14 May 2020 09:30
Last Modified: 14 May 2020 09:30
URI: https://pred.uni-regensburg.de/id/eprint/18842

Actions (login required)

View Item View Item